Literature DB >> 9360847

Snake venoms.

F S Markland1.   

Abstract

Snake venoms are complex mixtures containing many different biologically active proteins and peptides. A number of these proteins act on components of the haemostatic system in humans. The paper focuses on those venom constituents that affect the blood coagulation pathway, endothelial cells and platelets. Several highly purified venom enzymes have been used clinically as anticoagulants, and other venom proteins are being used in preclinical research to investigate their possible therapeutic potential. Haemostatically active components are distributed widely in the venom of many different snake species. In no case are all the components described below found in any single venom. Venom components can be grouped into several categories depending on their haemostatic effect. The following haemostatically active components are discussed in this chapter: enzymes that cause fibrinogen coagulation: enzymes that degrade fibrin(ogen); plasminogen activator; prothrombin activators; factor V activator; factor X activator; anticoagulant activities: enzymes with haemorrhagic activity; platelet aggregation inducers: and platelet aggregation inhibitors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360847     DOI: 10.2165/00003495-199700543-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  42 in total

Review 1.  Characterization of snake venom components acting on blood coagulation and platelet function.

Authors:  C Ouyang; C M Teng; T F Huang
Journal:  Toxicon       Date:  1992-09       Impact factor: 3.033

Review 2.  Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib.

Authors:  Y Fujimura; T Kawasaki; K Titani
Journal:  Thromb Haemost       Date:  1996-11       Impact factor: 5.249

3.  Purification and biochemical characterization of atroxase, a nonhemorrhagic fibrinolytic protease from western diamondback rattlesnake venom.

Authors:  T W Willis; A T Tu
Journal:  Biochemistry       Date:  1988-06-28       Impact factor: 3.162

4.  Inactivation of "Arvin" by plasma proteins.

Authors:  W R Pitney; E Regoeczi
Journal:  Br J Haematol       Date:  1970-07       Impact factor: 6.998

5.  Studies on a procoagulant fraction of southern copperhead snake venom: the preferential release of fibrinopeptide B.

Authors:  R H Herzig; O D Ratnoff; J R Shainoff
Journal:  J Lab Clin Med       Date:  1970-09

6.  Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell's viper venom.

Authors:  P A Lindquist; K Fujikawa; E W Davie
Journal:  J Biol Chem       Date:  1978-03-25       Impact factor: 5.157

7.  Coagulation factor X activating enzyme from Russell's viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains.

Authors:  H Takeya; S Nishida; T Miyata; S Kawada; Y Saisaka; T Morita; S Iwanaga
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

Review 8.  Hemorrhagic metalloproteinases from snake venoms.

Authors:  J B Bjarnason; J W Fox
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

9.  Analysis of the effects of snake venom proteinases on the activity of human plasma C1 esterase inhibitor, alpha 1-antichymotrypsin and alpha 2-antiplasmin.

Authors:  L F Kress; J Catanese; T Hirayama
Journal:  Biochim Biophys Acta       Date:  1983-06-15

10.  Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis.

Authors:  F S Markland; G S Friedrichs; S R Pewitt; B R Lucchesi
Journal:  Circulation       Date:  1994-11       Impact factor: 29.690

View more
  4 in total

1.  A catalog for the transcripts from the venomous structures of the caterpillar Lonomia obliqua: identification of the proteins potentially involved in the coagulation disorder and hemorrhagic syndrome.

Authors:  Ana B G Veiga; José M C Ribeiro; Jorge A Guimarães; Ivo M B Francischetti
Journal:  Gene       Date:  2005-08-01       Impact factor: 3.688

2.  Purification and characterization of a new cystatin inhibitor from Taiwan cobra (Naja naja atra) venom.

Authors:  M Brillard-Bourdet; V Nguyên; M Ferrer-di Martino; F Gauthier; T Moreau
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

Review 3.  Defibrinogenating enzymes.

Authors:  W R Bell
Journal:  Drugs       Date:  1997       Impact factor: 9.546

4.  Molecular docking studies and anti-enzymatic activities of Thai mango seed kernel extract against snake venoms.

Authors:  Jiraporn Leanpolchareanchai; Pimolpan Pithayanukul; Rapepol Bavovada; Patchreenart Saparpakorn
Journal:  Molecules       Date:  2009-03-31       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.